Amicus Therapeutics Q3 2018 Earnings Report

Total Revenue
$20.6M
Previous year: $10.9M
+89.4%
EPS
-$0.31
Previous year: -$0.41
-24.4%

Amicus Therapeutics

Amicus Therapeutics